Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse.
Blaise D, Maraninchi D, Archimbaud E, Reiffers J, Devergie A, Jouet JP, Milpied N, Attal M, Michallet M, Ifrah N, et al. Blaise D, et al. Among authors: milpied n. Blood. 1992 May 15;79(10):2578-82. Blood. 1992. PMID: 1586710 Free article. Clinical Trial.
Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? SFGM. Société Française de Greffe de Moelle.
Resbeut M, Cowen D, Blaise D, Gluckman E, Cosset JM, Rio B, Pene F, Milpied N, Cuillère JC, Reiffers J, et al. Resbeut M, et al. Among authors: milpied n. Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):509-17. doi: 10.1016/0360-3016(94)00446-r. Int J Radiat Oncol Biol Phys. 1995. PMID: 7852113 Clinical Trial.
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle.
Sutton L, Chastang C, Ribaud P, Jouet JP, Kuentz M, Attal M, Reiffers J, Tigaud JM, Rio B, Dauriac C, Legros M, Dreyfus F, Lioure B, Troussard X, Milpied N, Witz F, Oriol P, Cahn JY, Michallet M, Gluckman E, Ifrah N, Pico JL, Vilmer E, Leblond V. Sutton L, et al. Among authors: milpied n. Blood. 1996 Jul 1;88(1):358-65. Blood. 1996. PMID: 8704196 Free article.
Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission.
Blaise D, Maraninchi D, Michallet M, Reiffers J, Jouet JP, Milpied N, Devergie A, Attal M, Sotto JJ, Kuentz M, Ifrah N, Dauriac C, Bordigoni P, Gratecos N, Guilhot F, Guyotat D, Gluckman E, Vernant JP. Blaise D, et al. Among authors: milpied n. Blood. 2001 Jun 1;97(11):3669-71. doi: 10.1182/blood.v97.11.3669. Blood. 2001. PMID: 11392326 Free article. No abstract available.
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.
Gorin NC, Labopin M, Reiffers J, Milpied N, Blaise D, Witz F, de Witte T, Meloni G, Attal M, Bernal T, Rocha V; Acute Leukemia Working Party, European Cooperative Group for Blood and Marrow Transplantation. Gorin NC, et al. Among authors: milpied n. Blood. 2010 Oct 28;116(17):3157-62. doi: 10.1182/blood-2009-11-252197. Epub 2010 May 17. Blood. 2010. PMID: 20479285 Free article.
Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse.
Michel G, Gluckman E, Blaise D, Esperou-Bourdeau H, Vernant JP, Kuentz M, Bordigoni P, Milpied N, Rubie H, Thuret I, et al. Michel G, et al. Among authors: milpied n. J Clin Oncol. 1992 Dec;10(12):1865-9. doi: 10.1200/JCO.1992.10.12.1865. J Clin Oncol. 1992. PMID: 1453201
Double-intensive therapy in high-risk multiple myeloma.
Harousseau JL, Milpied N, Laporte JP, Collombat P, Facon T, Tigaud JD, Casassus P, Guilhot F, Ifrah N, Gandhour C. Harousseau JL, et al. Among authors: milpied n. Blood. 1992 Jun 1;79(11):2827-33. Blood. 1992. PMID: 1350228 Free article.
451 results